1.
Case Rep Med
; 2018: 2913124, 2018.
Artículo
en Inglés
| MEDLINE
| ID: mdl-30595697
RESUMEN
Bortezomib, a proteasome inhibitor, is an established therapy against multiple myeloma. Bortezomib-induced lung injury, although not appreciated during the introductory time of the medication, has now been highlighted in multiple case reports. The objective of this study is to report a case of bortezomib-induced lung injury, review current literature, and perform exploratory analysis.